Can strength training steady the walk and strengthen the pelvic floor after menopause?

NCT ID NCT07824947

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers at the University of Alcala are testing whether a three-month strength and balance training program changes walking patterns and pelvic floor muscle activity in sedentary menopausal women. Thirty-four women aged 45 to 77 will either join guided training sessions twice a week or continue without training. The study measures walking mechanics, pelvic floor electrical activity, urinary leakage, fracture risk, and sexual function to see if exercise makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a guided strength and balance training program
What this could lead to
If it works, this could offer a low-cost exercise option to help menopausal women walk more steadily and reduce pelvic floor problems like urinary leakage.
What could go wrong
This is a small early-phase study of 34 women, so any changes may be modest or not hold up in larger groups. Exercise programs also depend on people sticking with them, and results may not apply to women who are not sedentary or who have different health profiles.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 1

The first testing in people. Mainly checks safety and dose, usually in a small group.

Participants

34 people

The number who actually took part.

Started

Apr 2023

Finished

Jan 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 77 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Women over 45 years of age and under 77 years of age in menopausal period (minimum 12 months of amenorrhea) who have read the information sheet, completed the informed consent and meet the following inclusion criteria will participate in the study: Sedentary lifestyle described as less than 30 minutes per day of regular exercise and less than 3 days per week according to the WHO definition of regular physical activity. Availability to participate in the study and to attend all the scheduled sessions. Be able to read and write and have a command of the spoken and written Spanish language. Have a diagnosis of urinary incontinence and/or pelvic organ prolapse and/or sexual dysfunction. Exclusion Criteria: Systemic disease Cardiovascular disease Vestibular and/or visual pathology including clinical symptoms of vertigo, tinnitus, hypoacusis and/or aural tinnitus History of psychiatric illness Cognitive deficits for any reason Neurological injury Walking aids, orthoses or prostheses Ingestion of vestibular sedatives or other central nervous system depressants Musculoskeletal diseases with lower limb deformity Lower limb surgery within the last 10 years Urogenital surgery Latex allergy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gait, unsteady are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Gait Disorders, Neurologic Mobility Limitation Orgasm Pelvic Floor Disorders pelvic organ prolapse Prolapse Urinary Incontinence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universidad Europea de Madrid

    Madrid, Villaviciosa de ODON, 28670, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.